Neural Progenitor Cell Sparing Radiation Therapy Plus Temozolomide
Status:
Completed
Trial end date:
2018-04-25
Target enrollment:
Participant gender:
Summary
The long term goal of this research is to establish whether NPC sparing RT techniques improve
neurocognitive outcomes compared to conventional RT for brain tumors. If the proposed study
demonstrates that NPC sparing RT is not associated with increased LR in the spared regions of
the brain compared to conventional RT, it will ideally serve as the foundation for a future
multi-institutional randomized controlled trial comparing neurocognitive outcomes in patients
treated with NPC-sparing RT versus conventional radiation therapy.
Phase:
N/A
Details
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins